Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-041519
Filing Date
2013-05-14
Accepted
2013-05-14 17:34:13
Documents
1
Period of Report
2013-05-14

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 10592
  Complete submission text file 0001104659-13-041519.txt   12436
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121 (858) 652-5712
Receptos, Inc. (Issuer) CIK: 0001463729 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Reporting) CIK: 0001575852 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35900 | Film No.: 13842893